Middle East Healthcare Company (TADAWUL:4009)
Saudi Arabia · Delayed Price · Currency is SAR 33.98
-0.02 (-0.06%)
May 21, 2026, 3:16 PM AST
TADAWUL:4009 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,134 | 3,103 | 2,883 | 2,653 | 2,152 | 1,873 | |
Revenue Growth (YoY) | 7.06% | 7.63% | 8.66% | 23.30% | 14.90% | 6.97% |
Cost of Revenue | 1,956 | 1,956 | 1,781 | 1,649 | 1,480 | 1,277 |
Gross Profit | 1,178 | 1,146 | 1,102 | 1,004 | 671.99 | 595.14 |
Selling, General & Admin | 758.86 | 758.86 | 661.1 | 679.76 | 531.65 | 540.9 |
Operating Expenses | 925.14 | 758.86 | 661.1 | 679.76 | 531.65 | 540.9 |
Operating Income | 252.51 | 387.3 | 440.93 | 323.97 | 140.34 | 54.24 |
Interest Expense | -192.81 | -192.81 | -220.59 | -153.18 | -69.01 | -41.52 |
Earnings From Equity Investments | -13.86 | -13.86 | -0.52 | - | - | - |
Other Non Operating Income (Expenses) | 31.6 | 31.6 | 25.83 | 20.9 | 11.87 | 8.19 |
EBT Excluding Unusual Items | 77.45 | 212.23 | 245.65 | 191.69 | 83.2 | 20.91 |
Merger & Restructuring Charges | - | - | 45.45 | - | - | - |
Gain (Loss) on Sale of Assets | 113.26 | 113.26 | 19.06 | -0.76 | -1.98 | -1.68 |
Pretax Income | 190.71 | 325.49 | 310.16 | 190.94 | 81.22 | 19.23 |
Income Tax Expense | 15.68 | 16.03 | 26.28 | 170.44 | 9.62 | 7.5 |
Earnings From Continuing Operations | 175.03 | 309.46 | 283.89 | 20.5 | 71.6 | 11.73 |
Minority Interest in Earnings | -7.58 | -7.58 | -1.88 | -3.46 | 3.58 | 5.47 |
Net Income | 167.45 | 301.88 | 282 | 17.04 | 75.18 | 17.2 |
Net Income to Common | 167.45 | 301.88 | 282 | 17.04 | 75.18 | 17.2 |
Net Income Growth | -57.94% | 7.05% | 1555.09% | -77.34% | 337.08% | -79.02% |
Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | 92 |
Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | 92 |
Shares Change (YoY) | -0.07% | - | - | - | - | - |
EPS (Basic) | 1.82 | 3.28 | 3.06 | 0.19 | 0.82 | 0.19 |
EPS (Diluted) | 1.82 | 3.28 | 3.06 | 0.19 | 0.82 | 0.19 |
EPS Growth | -57.91% | 7.05% | 1555.10% | -77.34% | 337.08% | -79.02% |
Free Cash Flow | 81.67 | 89.44 | 295.18 | -38.53 | -173.5 | -339.94 |
Free Cash Flow Per Share | 0.89 | 0.97 | 3.21 | -0.42 | -1.89 | -3.69 |
Dividend Per Share | 0.500 | 0.500 | 0.500 | - | - | - |
Gross Margin | 37.57% | 36.94% | 38.23% | 37.83% | 31.23% | 31.78% |
Operating Margin | 8.06% | 12.48% | 15.29% | 12.21% | 6.52% | 2.90% |
Profit Margin | 5.34% | 9.73% | 9.78% | 0.64% | 3.49% | 0.92% |
Free Cash Flow Margin | 2.61% | 2.88% | 10.24% | -1.45% | -8.06% | -18.15% |
EBITDA | 464.77 | 599.97 | 628.82 | 497.7 | 269.9 | 185.15 |
EBITDA Margin | 14.83% | 19.34% | 21.81% | 18.76% | 12.54% | 9.89% |
D&A For EBITDA | 212.26 | 212.68 | 187.88 | 173.73 | 129.56 | 130.91 |
EBIT | 252.51 | 387.3 | 440.93 | 323.97 | 140.34 | 54.24 |
EBIT Margin | 8.06% | 12.48% | 15.29% | 12.21% | 6.52% | 2.90% |
Effective Tax Rate | 8.22% | 4.92% | 8.47% | 89.27% | 11.84% | 39.00% |
Advertising Expenses | - | 15.47 | 16.39 | 9.74 | 7.59 | 7.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.